Fluid production by in vitro lungs from fetal guinea pigs

1990 ◽  
Vol 68 (4) ◽  
pp. 505-513 ◽  
Author(s):  
A. M. Perks ◽  
J. J. Dore ◽  
R. Dyer ◽  
J. Thom ◽  
J. K. Marshall ◽  
...  

Lungs from fetal guinea pigs (54–67 days of gestation) were supported in vitro, and lung liquid secretion rates were measured by a dye-dilution technique. The average secretion rate in the first hour was 2.14 ± 0.08 (SE) mL∙kg−1 body weight∙h−1 (0.21 ± 0.01 mL/h) (n = 450); this was comparable to intact preparations. In an independent study of 30 lungs, secretion continued unchanged for 3 h, with no significant change in fluid composition. Between 54 days and term, production appeared to fall in terms of millilitres per kilogram per hour. The following agents were placed in the supporting saline during the middle hour of incubation. (i) Sodium iodoacetate: at 10−4 M this produced a fall in secretion (fall, succeeding hours; 55.4 ± 23.0 and 64.9 ± 17.5%; n = 6); at 10−3 M it stopped secretion (fall, succeeding hours; 87.2 ± 10.3 and 100%, n = 6). (ii) Ouabain: at 10−5 M there was no change in production (n = 6); at 10−4 M, four preparations were unaffected, two reduced production. (iii) Epinephrine (10−7 M) produced a significant fall in production in all cases (n = 6); in four preparations secretion reduced (average fall, 64.4 ± 10.8%); in two preparations there was reabsorption (average rate, −1.03 mL∙kg−1∙h−1). This extends the effect of epinephrine to the guinea pig, and suggests that the in vitro preparation is a useful model for studies of the fetal lung.Key words: fetus, lung fluid, secretion, iodoacetate, epinephrine.

1990 ◽  
Vol 68 (8) ◽  
pp. 1131-1135 ◽  
Author(s):  
J. Thom ◽  
A. M. Perks

Lungs from fetal guinea pigs of 61 ± 3 days of gestation were supported in vitro for 3 h, and lung liquid secretion rates were measured by a dye dilution technique based on Blue Dextran 2000. Ten preparations that had received no treatment showed an average secretion rate of 1.12 ± 0.28 mL∙kg−1 body weight∙h−1 during the first hour, and there were no significant changes over the following 2 h. In studies of 54 fetal lungs, furosemide, bumetanide, control ethanol carrier, or saline alone were placed in the supporting medium during the middle hour of the 3-h incubations (ABA design). Furosemide at 10−3 M reduced secretion 83.4 ± 16.8%; at 10−4 and 10−5 M it produced smaller reductions. Bumetanide at 10−3 M usually produced reabsorption (129.9 ± 23.0% reduction), at 10−4 M it reduced secretion 30.9 ± 11.8%, but at 10−5 M it was ineffective. Control carrier and saline were without effect. The ability of the loop diuretics to produce reabsorption of fluid in some preparations suggests the unmasking of an active reabsorptive process. The results also suggest that lung liquid secretion in the fetal guinea pig, as in the sheep, is dependent on a Na+ and Cl− cotransport system.Key words: fetus, lung fluid, bumetanide, furosemide.


1996 ◽  
Vol 8 (3) ◽  
pp. 347 ◽  
Author(s):  
PG Nelson ◽  
AM Perks

Lungs from near-term fetal guinea-pigs were supported in vitro for 3 h; lung liquid production was measured by a dye-dilution method using Blue Dextran 2000 [fetuses 63 +/- 2 days of gestation, 97.6 +/- 19.8 (SD) g body weight]. Preparations were incubated in pairs taken from the same mother. Twenty lungs incubated in pairs without treatment (controls) showed no significant changes in fluid production throughout incubation (analysis of variance; regression analysis); rates in successive hours were: first lung, 1.36 +/- 0.39, 1.09 +/- 0.34 and 1.27 +/- 0.42 ml/kg body weight per h; second lung, 1.46 +/- 0.52, 1.09 +/- 0.41 and 1.18 +/- 0.43 ml/kg body weight per h. Twenty lungs were incubated similarly in pairs, but after one hour one lung from each pair was expanded with Krebs-Henseleit saline in volumes approximating those of the first breath (68 +/- 10% of lung volume). The expanded lungs began to reabsorb fluid immediately after expansion; the untreated lungs also stopped production or reached reabsorption by the final hour. Rates in successive hours were: expanded lungs; before expansion, 1.00 +/- 0.21, after expansion, -0.23 +/- 0.17 and 0.14 +/- 0.09 ml/kg body weight per h; unexpanded lungs, 1.27 +/- 0.49, 0.02 +/- 0.01 and -0.01 +/- 0.004 ml/kg body weight per h. The decrease in production was significant for each type of lung. The effects persisted in both expanded and unexpanded lungs in the presence of 1.78 x 10(-5) M phentolamine (n = 12; 70 +/- 2% expansion). The results suggest that expansion of the lungs at birth may release an unknown inhibitory factor, provisionally termed Expansion Factor (EF), within the lungs; this agent, probably not a catecholamine, can change lung fluid production into reabsorption and may partly account for the failure of beta-antagonists to prevent fluid reabsorption at delivery.


1992 ◽  
Vol 70 (3) ◽  
pp. 330-337 ◽  
Author(s):  
Pawel M. Kindler ◽  
Sepideh Ziabakhsh ◽  
Anthony M. Perks

Lungs from fetal guinea pigs (62 ± 1 days of gestation) were supported in vitro for 3 h and fluid production was determined by a dye dilution method, based on Blue Dextran 2000. Twenty untreated lungs produced fluid at 1.41 ± 0.22 mL∙kg−1 body weight∙h−1, with no significant changes during later hours. Treatments with analogues of cAMP, cAMP, or forskolin during the middle hour reduced production significantly. Dibutyryl cAMP at 10−3 M produced reabsorption (117.8 ± 13.6% reduction, p < 0.001, n = 10); at 10−4 M it reduced production (77.3 ± 11.0% fall, p < 0.001, n = 10). 8-Bromo-cAMP appeared more effective; at 10−4 M it caused slight reabsorption (109.0 ± 8.9% reduction, p < 0.001, n = 6) and at lower concentrations it decreased production (at 10−6 M, 67.6 ± 9.6% fall, p < 0.001, n = 6; at 10−7 M, 40.0 ± 14.3% fall, p < 0.001, n = 6). At high doses, cAMP itself produced similar effects (at 5 × 10−3 M, 141.6 ± 22.8% reduction, p < 0.001, n = 6); at 10−4 it was ineffective (n = 3). Forskolin at 10−6 M induced the strongest reabsorptions seen (159.1 ± 10.9% reduction, p < 0.001, n = 6); at lower concentrations it reduced production (at 10−8 M, 73.8 ± 5.5% fall, p < 0.001, n = 6; at 10−9 M, 29.2 ± 9.2% fall, p < 0.05, n = 6). These results suggest a possible role for the adenylate cyclase system in the arrest of lung liquid production in the guinea pig around birth.Key words: cAMP, forskolin, fetal lung, lung fluid.


1997 ◽  
Vol 75 (7) ◽  
pp. 1147-1154 ◽  
Author(s):  
A. M. Perks ◽  
M. Stockbrocks ◽  
D. C. Chuang ◽  
I. Vonder Muhll ◽  
P. W. Kindler

Lungs from near-term fetal guinea pigs (62 ± 2 days of gestation) were supported in vitro for 3 h; lung-liquid production was monitored by a dye-dilution method based on Blue Dextran 2000. Untreated preparations produced fluid at 1.26 ± 0.14 mL∙kg−1 body mass∙h−1, with no significant change over the ensuing hours (ANOVA, regression analysis; n = 16). Experimental preparations received aldosterone at plasma concentrations reported to be present at birth. Aldosterone produced rapid, significant reductions in fluid production, and occasionally reabsorptions, which persisted beyond treatment. Reductions during treatment were as follows: 10−8 M aldosterone, 90.8 ± 4.9% (P < 0.001; n = 4); 2 × 10−9 M aldosterone, 64.1 ± 16.6% (P < 0.05–0.001; n = 6), and 7 × 10−10 M aldosterone, 48.6 ± 11.7% (P < 0.005–0.001; n = 6). The linear log dose response curve (r = 0.99) showed a theoretical threshold at 3.4 × 10−11 M aldosterone. Responses to 7 × 10−10 M aldosterone were abolished by 10−6 M amiloride. At the highest concentration of aldosterone (10−8 M), 10−6 M amiloride significantly reduced responses, and the changes were no longer significant by ANOVA. At both high and low aldosterone concentrations, responses with amiloride were significantly lower than those without amiloride (ANOVA, P < 0.03–0.04). Amiloride controls and untreated preparations showed no significant changes in fluid production. It is concluded that aldosterone at plasma concentrations present at birth can cause reductions in lung-liquid production or reabsorption through effects on amiloride-sensitive Na+ channels, and that the responses are remarkably rapid.


1993 ◽  
Vol 71 (1) ◽  
pp. 1-11 ◽  
Author(s):  
A. M. Perks ◽  
T. Ruiz ◽  
B. Chua ◽  
I. Vonder Muhll ◽  
P. M. Kindler ◽  
...  

Lungs from near-term fetal guinea pigs (62 ± 2 days of gestation) were supported in vitro for 3 h, and lung liquid production was measured by a dye dilution technique. Twelve untreated preparations produced fluid at 1.54 ± 0.29 mL∙kg−1 body weight∙h−1 during the 1st h, with no significant changes in later hours. Twelve preparations treated with 2 × 10−4 M 2,4-dinitrophenol (DNP) showed strong reabsorptions (significant, ANOVA and regression analysis); total loss of lactate from the preparations doubled (significant, same tests). In 12 additional preparations, increasing DNP fivefold did not abolish reabsorption; results resembled those at the lower concentration. Amiloride at 10−6 M abolished reabsorptions after 2 × 10−4 M DNP, although fluid production still halted (n = 6; reductions significant, same tests). Amiloride alone had no effect (n = 6); untreated controls showed no change (n = 6). Similarly, 10−4 M sodium iodoacetate virtually abolished reabsorptions after 2 × 10−4 M DNP, although fluid production still stopped (n = 6; reductions significant, same tests). Iodoacetate alone only reduced fluid production (n = 6; significant, same tests); untreated controls showed no change (n = 6). The results suggest that reabsorptions seen after inhibition of oxidative processes depend on amiloride-sensitive Na+ channels and glycolytic metabolism.Key words: fetus, lung liquid, 2,4-dinitrophenol, amiloride, iodoacetate.


1998 ◽  
Vol 84 (2) ◽  
pp. 746-753 ◽  
Author(s):  
S. Doe ◽  
A. M. Perks

Doe, S., and A. M. Perks. α-Adrenoreceptor influences on liquid movements by in vitro lungs from fetal guinea pigs. J. Appl. Physiol. 84(2): 746–753, 1998.—Lungs from near-term fetal guinea pigs (60 ± 2 days of gestation) were supported in vitro for 3 h; lung liquid production was monitored by a dye-dilution method. Studies of 30 fetuses showed that untreated preparations produced fluid at 1.34 ± 0.21 ml ⋅ h−1 ⋅ kg body wt−1, but epinephrine at concentrations known at delivery (10−8 and 10−7 M) produced significant reductions or fluid reabsorption (analysis of variance, regression analysis); at high levels (10−6 and 10−5 M), epinephrine had no effect. Maximal responses from 10−7 M epinephrine involved α-adrenoreceptors, since they were abolished by 10−6 M phentolamine (α-antagonist) but were unaffected by 10−6 M propranolol (β-antagonist; n = 36). Activation was through α2-adrenoreceptors, since responses were abolished by 10−4 M yohimbine (α2-antagonist; n = 24) but were resistant to 10−5 M prazosin (α1-antagonist; n = 24). At high levels of epinephrine (10−5 M), where responses did not normally occur, reductions in lung liquid production were large if prazosin was also present ( n = 24), and increases were significant if yohimbine was included ( n = 24). In guinea pigs, epinephrine appears to activate lung fluid reabsorption through α2-adrenoreceptors; at high concentrations only, it can also increase production through α1-adrenoreceptors. Therefore, species differences appear to exist.


1993 ◽  
Vol 129 (2) ◽  
pp. 169-177 ◽  
Author(s):  
Pawel M Kindler ◽  
Deuel C Chuang ◽  
Anthony M Perks

Lungs from near-term fetal guinea pigs (62±1 days of gestation) were supported in vitro for 3 h and fluid production was determined by a dye dilution method (Blue Dextran 2000). Three groups of control preparations (N =6 for each group) showed no changes during incubation. However, cortisol or aldosterone placed in the outer saline during the middle hour caused profound reductions in fluid production. Cortisol at 10−6 or 10−8 mol/l reduced production 80.3±10.8% and 47.8±20.5%, respectively (p<0.05–0.001; N=6 for each group); at 10−10 mol/l it failed to affect production significantly. Aldosterone was effective at lower concentrations (N=12). At 10−11 mol/l it reduced production 67.1±10.0% (p<0.01–0.001); at 7× 10−10 mol/l it produced similar effects. In contrast, there were no significant changes after treatment with 10−11 mol/l aldosterone together with an aldosterone antagonist (5 × 10−8 mol/l spironolactone; N = 6). Spironolactone alone was without effect (N = 6). The highest steroid concentrations tested corresponded to plasma concentrations in the guinea pig at delivery; therefore, it is suggested that both steroids may have a role in reducing lung fluid production close to birth in this species.


1992 ◽  
Vol 262 (3) ◽  
pp. L270-L279 ◽  
Author(s):  
P. B. McCray ◽  
J. D. Bettencourt ◽  
J. Bastacky

We studied human fetal lung tissue in submersion organ culture to determine whether the bronchopulmonary epithelium secretes fluid during development. In this system the acinar tubules continued to grow, secrete fluid, and become progressively dilated. Baseline transepithelial potential differences (psi t) of -0.5 to -11 mV (mean, -3.8 mV, lumen negative, n = 27) were measured with microelectrodes after 3-8 days in culture, suggesting active electrolyte transport. Bumetanide (500 microM), an inhibitor of chloride secretion in other systems, decreased the basal psi t from -5 +/- 1.5 to -3.2 +/- 1.6 (SE) mV (P less than 0.05, n = 6), suggesting that chloride transport contributed to the voltage. Isoproterenol (5 microM) increased the baseline psi t from -5.6 +/- 2.1 to -9.2 +/- 2.5 (SE) mV (P less than 0.05, n = 4). Subsequent addition of bumetanide inhibited the isoproterenol-induced stimulation of the psi t by 20% (P less than 0.05). 8-(4-chlorophenylthio)adenosine 3',5'-cyclic monophosphate. (CPT-cAMP, 50 microM) and 3-isobutyl 1-methylxanthine (IBMX, 100 microM) had similar effects, causing an increase in the psi t from -2.2 +/- 0.5 to -8 +/- 1.6 (SE) mV, an effect that was inhibited by the addition of bumetanide (P less than 0.005, n = 6). Both isoproterenol and CPT-cAMP/IBMX produced significant increases in the percentage luminal area of the explants at 12 and 24 h after exposure compared with control. We conclude that 1) the developing bronchopulmonary epithelium (acinar tubules) contributes to lung fluid production in the human fetus, 2) fetal lung fluid secretion is chloride dependent, and 3) chloride secretion and fluid secretion may be stimulated by a beta-agonist and cAMP.


2002 ◽  
Vol 282 (5) ◽  
pp. R1297-R1307 ◽  
Author(s):  
Laura Kean ◽  
William Cazenave ◽  
Laurence Costes ◽  
Kate E. Broderick ◽  
Shirley Graham ◽  
...  

A Drosophila gene ( capability, capa) at 99D on chromosome 3R potentially encodes three neuropeptides: GANMGLYAFPRV-amide (capa-1), ASGLVAFPRV-amide (capa-2), and TGPSASSGLWGPRL-amide (capa-3). Capa-1 and capa-2 are related to the lepidopteran hormone cardioacceleratory peptide 2b, while capa-3 is a novel member of the pheromone biosynthesis-activating neuropeptide/diapause hormone/pyrokinin family. By immunocytochemistry, we identified four pairs of neuroendocrine cells likely to release the capa peptides into the hemolymph: one pair in the subesophageal ganglion and the other three in the abdominal neuromeres. In the Malpighian (renal) tubule, capa-1 and capa-2 increase fluid secretion rates, stimulate nitric oxide production, and elevate intracellular Ca2+ and cGMP in principal cells. Capa-stimulated fluid secretion, but not intracellular Ca2+ concentration rise, is inhibited by the guanylate cyclase inhibitor methylene blue. The actions of capa-1 and capa-2 are not synergistic, implying that both act on the same pathways in tubules. The capa gene is thus the first to be shown to encode neuropeptides that act on renal fluid production through nitric oxide.


Sign in / Sign up

Export Citation Format

Share Document